Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

作者：Shukui Qin, Shukui Qin, Stephen L Chan, Shanzhi Gu, Yuxian Bai, Zhenggang Ren, Xiaoyan Lin, Zhendong Chen, Yongdong Jin, Yongdong Jin, Yabing Guo, Xiaohua Hu, Zhiqiang Meng, Jun Liang, Ying Cheng, Jianping Xiong, Hong Ren, Fang Yang, Wei Li, Yajin Chen, Yong Zeng, Alexander Sultanbaev, Monika Pazgan-Simon, Margaryta Pisetska, Davide Melisi, Dmitriy Ponomarenko, Yurii Osypchuk, Ivan Sinielnikov, Tsai-Sheng Yang, Xiao Liang, Chunxia Chen, Linna Wang, Ann-Lii Cheng, Ahmed Kaseb, Arndt Vogel, Shukui Qin, Shukui Qin, Stephen L Chan, Ann-Lii Cheng, Ahmed Kaseb, Arndt Vogel, Shanzhi Gu, Yuxian Bai, Zhenggang Ren, Xiaoyan Lin, Zhendong Chen, Weidong Jia, Yongdong Jin, Yabing Guo, Xiaohua Hu, Zhiqiang Meng, Jun Liang, Ying Cheng, Jianping Xiong, Hong Ren, Fang Yang, Wei Li, Yajin Chen, Yong Zeng, Alexander Sultanbaev, Monika Pazgan-Simon, Margaryta Pisetska, Davide Melisi, Dmitriy Ponomarenko, Yurii Osypchuk, Ivan Sinielnikov, Tsai-Sheng Yang, Xiao Liang, Chunxia Chen, Linna Wang, Mingxiang Zhang, Li Xu, Xianglin Yuan, Da Li, Jierer Ying, Jingdong Zhang, Tao Zhang, Kangsheng Gu, Yifu He, Ping Hao, Da Jiang, Shu Zhang, Baocai Xing, Baihong Zhang, Dong Wang, Xiaofeng Zhai, Houjie Liang, Bożena Cybulska-Stopa, Mikhail Dvorkin, Daniil Stroyakovskiy, M. Nechaeva, Chia‐Jui Yen, Wei‐Wen Su, Yen‐Hao Chen, Igor Bondarenko, Lin Yang, Weijia Fang, Carlos Gómez-Martín, Min‐Hee Ryu, Hansang Kim, Jeehyun Kim, Oleg Zarubenkov, Р. В. Орлова, Elena Poddubskaya, Natalia Fadeeva, Yulia Makarova, Yee Chao, Chao‐Hung Hung, Maryna Neffa, О. І. Vynnychenko, Adam M. Burgoyne, Chunyi Hao, Raphael Mohr, Robert Díaz Beveridge, Jaime Feliú-Batlle, Antonio Cubillo-Gracian, Ann‐Shing Lee, Bruno Daniele, Lorenzo Antonuzzo, Angelo Sangiovanni, Antonio Gasbarrini, Mario Scartozzi, Mi Sun Ahn, Sung‐Yong Oh, С. В. Орлов, Hakan Harputluoğlu, Berna Öksüzoğlu, Chiun Hsu, Kun‐Ming Rau, Oleksandr Krechkovskyi, Vladimir Yareshko, Henry Xiong, Fa-Chyi Lee, Yixing Jiang, Afshin Eli Gabayan, Mary K. Crow, Christophe Van Steenkiste, Gontran Verset · 发表于：The Lancet · 年份：2023 · DOI：10.1016/s0140-6736(23)00961-3 · 被引用次数：721 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Cholangiocarcinoma and Gallbladder Cancer Studies、Cancer Immunotherapy and Biomarkers